Here are some of the developments in antitrust news this past week that we found interesting and are following.
Bipartisan U.S. bill to raise merger fees for big deals passes Senate panel. A bill to increase the fees that companies planning the biggest mergers pay to government antitrust agencies and to give those agencies bigger budgets passed the Senate Judiciary Committee on Thursday on a voice vote. The bill -...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
EU hopes new foreign buyer rules agreed within next year. The European Union’s antitrust chief is hopeful draft rules intended to curb state-backed foreign buyers will be agreed within the next year, she said on Thursday. The rules aim to prevent companies that benefit from distorting foreign subsidies...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
U.S. lawmakers introduce eight antitrust bills aimed at drug prices. U.S. lawmakers from both parties and both houses of Congress have introduced eight antitrust bills aimed at tackling the problem of high and rising drug prices, including bills to stop brand name drug companies from paying generic firms...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
What U.S. Supreme Court took away from the FTC, Congress can give back. The U.S. Supreme Court, by a 9-0 vote, on Thursday gutted the Federal Trade Commission's ability to force scam artists and companies that acted deceptively to return ill-gotten gains, ruling in favor of a criminally convicted payday...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
4th Circuit revives antitrust claims against Actelion over Tracleer pricing. The 4th U.S. Circuit Court of Appeals on Tuesday revived a proposed class action against Janssen’s Actelion Pharmaceuticals Ltd accusing the company of extending its patent monopoly on its pulmonary artery hypertension drug...
Facebook purchase of Kustomer may face EU antitrust scrutiny. Facebook’s acquisition of customer service startup Kustomer may be subjected to European Union antitrust scrutiny after Austria asked EU enforcers to take over the task, the European Commission said on Tuesday. The move comes as the EU competition regulator girds up to vet more tech, pharma and biotech startup deals, sending a warning about so-called...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
U.S. trade regulator will not appeal Qualcomm case to Supreme Court. The Federal Trade Commission said it would not ask the U.S. Supreme Court to review its appeals court loss against Qualcomm Inc, which the agency had accused of breaking antitrust law in selling chips for smartphones. In October, the...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
NCAA takes on student-athletes in U.S. Supreme Court compensation dispute. As the annual U.S. ritual of the “March Madness” college basketball tournament unfolds, the Supreme Court is poised to hear the National Collegiate Athletic Association’s bid to preserve its limits on education-related...
Here are some of the developments in antitrust news this past week that we found interesting and are following.
U.S. Justice Department probing Visa over debit practices. The Justice Department is looking at Visa Inc’s debit practices, the company said on Friday, after reports the United States was investigating whether the credit card company uses anticompetitive practices in the debit-card market. “The U.S....
Here are some of the developments in antitrust news this past week that we found interesting and are following.
U.S. lawmakers discuss antitrust exemption for media. Lawmakers heard testimony on Friday over whether a bill aimed at helping news outlets negotiate with tech platforms was an appropriate way to help the struggling industry, including discussion of whether it should be restricted to smaller news...